GP practices to help identify patients for community COVID drug trials GPs will help to identify patients eligible for COVID-19 antiviral and antibody treatments as part of trials in the community, the government has announced. by Luke Haynes Sign in to continue Sign In Email address Password Stay signed in Trouble signing in? Reset password: Click here Need help? Email us Register FREE Limited free articles a month Free email bulletins Register Now Register Now Take a 30-day trial Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days Sign Up Sign Up
